Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mary Lou Valdez"'
Autor:
Jarbas Barbosa da Silva Jr., Nísia Trindade Lima, Ana Estela Haddad, Socorro Gross Galiano, Sebastian Garcia Saiso, Mary Lou Valdez, James Fitzgerald, Mariana Faria Teixeira, Ernesto Bascolo, Daniel Rodriguez, Luis Jimenez McInnis, Judit Rius Sanjuan, Myrna Marti, Daniel Luna, Paula Kohan, Marcelo DAgostino
Publikováno v:
Revista Panamericana de Salud Pública, Vol 48, Iss 73, Pp 1-3 (2024)
Externí odkaz:
https://doaj.org/article/0d7bdbf44e7849c6b9e58d8976443ad0
Publikováno v:
PLoS Medicine, Vol 9, Iss 10, p e1001327 (2012)
In summary, the case studies exploring global product supply chains and diethylene glycol poisoning in Panama, clinical trials regulation through AVAREF, premarket assurance through PEPFAR tentative approval, post-market surveillance in sub-Saharan A
Externí odkaz:
https://doaj.org/article/fa88186e58444da6a7d471b7873d23c8
Autor:
Li Bo, Jarbas Barbosa de Silva Junior, Primal Silva, Hans-Georg Eichler, Chia-Ding Liao, Tara S. Barton-Maclaren, Mary Lou Valdez, Meiruze Freitas, Thalita Antony de Souza Lima, Maurice Whelan, Frank D. Sistare, William Slikker, Shraddha Thakkar, Carl Sactitono, Gary Van Domselaar, Kenneth Lee, Davide Archella, Anil K. Patri, Orish Ebere Orisakwe, Leming Shi, Anna Zhao-Wong, Barry Hardy, Peiying Chuan, Danitza Buvinich, Lit-Hsin Loo, Qasim Chaudhry, Marta Hugas, Haruhiro Okuda, Weida Tong, Hubert Deluyker
Publikováno v:
Regulatory Toxicology and Pharmacology. 98:115-128
Emerging technologies are playing a major role in the generation of new approaches to assess the safety of both foods and drugs. However, the integration of emerging technologies in the regulatory decision-making process requires rigorous assessment
Autor:
Peter Capella, Karen Riley, Mary Lou Valdez, Jeffrey S. Murray, Harinder Singh Chahal, Kalli Koukounas, Martin Shimer, Ryan Presto
Publikováno v:
JAMA Network Open
Key Points Question What has the US Food and Drug Administration (FDA) program to review antiretroviral drugs for use in low-resource settings via the US President’s Emergency Plan for AIDS Relief (PEPFAR) achieved since its inception in 2004, and
Autor:
Ryan Presto, Jeffrey S. Murray, Harinder Singh Chahal, Mary Lou Valdez, Peter Capella, Peter Lurie, Martin Shimer
Publikováno v:
BMJ Global Health
BackgroundSince 2004, the US Food and Drug Administration’s (USFDA) dedicated drug review process in support of President’s Emergency Plan for AIDS Relief (PEPFAR) has made safe, effective and quality antiretrovirals (ARVs) available for millions
Autor:
Jim E. Riviere, Thomas Hughes, Gillian J. Buckley, Llc Martha A. Brumfield, Lembit Rägo, Martha Brumfield, Stacy Kane, Mary Morrison, Mary Lou Valdez, Margaret Ann Miller, Samvel Azatyan, Charles Preston, Gerald Wojtala, Julia Bradsher, Sherry Keramidas, Tammie Bell, Katherine Bond
Publikováno v:
NAM Perspectives. 3
Publikováno v:
PLoS Medicine, Vol 9, Iss 10, p e1001327 (2012)
PLoS Medicine
PLoS Medicine
In summary, the case studies exploring global product supply chains and diethylene glycol poisoning in Panama, clinical trials regulation through AVAREF, premarket assurance through PEPFAR tentative approval, post-market surveillance in sub-Saharan A